Expression and Subcellular Localization of the Cyclin-Dependent Kinase Inhibitor p27 Kip1 in Epithelial Ovarian Cancer

By Hurteau J.A.   Allison B.M.   Brutkiewicz S.A.   Goebl M.G.   Heilman D.K.   Bigsby R.M.   Harrington M.A.  

Gynecologic Oncology, Vol. 83, Iss. 2, 2001-11 ,pp. : 292-298

Elsevier

Access to resources Recommend Favorite

Frequent loss of expression of the cyclin-dependent kinase inhibitor p27 (Kip1) in estrogen-related endometrial adenocarcinomas

By Torricelli Michela   Sanseverino Francesca  

The Women's Oncology Review, Vol. 4, Iss. 1, 2004-01 ,pp. : 19-20

Informa Healthcare

Access to resources Recommend Favorite

Overexpression of a Stabilized Mutant Form of the Cyclin-Dependent Kinase Inhibitor p27^Kip1 Inhibits Cell Growth

By Hurteau J.A.   Brutkiewicz S.A.   Wang Q.   Allison B.M.   Goebl M.G.   Harrington M.A.  

Gynecologic Oncology, Vol. 86, Iss. 1, 2002-07 ,pp. : 19-23

Academic Press

Access to resources Recommend Favorite

Cyclin Dependent Kinase as Significant Target for Cancer Treatment

By  

Current Cancer Therapy Reviews, Vol. 8, Iss. 3, 2012-08 ,pp. : 225-235

Bentham Science Publishers

Access to resources Recommend Favorite

X-Ray Crystallographic Studies of CDK2, a Basis for Cyclin-Dependent Kinase Inhibitor Design in Anti-Cancer Drug Research

By  

Current Medicinal Chemistry - Anti-Cancer Agents, Vol. 3, Iss. 1, 2003-01 ,pp. : 15-23

Bentham Science Publishers

Access to resources Recommend Favorite